Hormone changes in relation to the time of fetal death after prostaglandin-induced abortion.
The changes in unconjugated estradiol-17beta and estriol, progesterone and chorionic somatomammotropin (HCS) in peripheral plasma have been studied in 18 women at 30-minute intervals following intra-uterine prostaglandin E2 administration for therapeutic termination of second trimester pregnancy. The hormonal changes were related to the time of fetal death detected by the disappearance of fetal heart pulsations. Prostaglandin E2 was given by the intra-amniotic route with urea (5 patients) or with intravenous oxytocin (5 patients), or by the extra-amniotic route with intravenous oxytocin (8 patients). Fetal death occurred rapidly with intra-amniotic PGE2, but usually at a late stage with extra-amniotic PGE2. Three fetuses in the extra-amniotic group died at or just before abortion. A variety of fetal heart changes were noted and the time of fetal death did not appear to influence the time of abortion within each treatment subgroup. Estradiol and estriol showed a sligh but persistent fall over 24 hours prior to induction of abortion. A more rapid fall usually occurred after induction, with a consistent fall around the time of fetal death. Progesterone and HCS usually fell much less before and immediately after fetal death. A marked rise in estradiol sometimes occurred before fetal death, particularly in the intraamniotic PGE2 and urea subgroup. Estriol levels declined more rapidly before than after fetal death, whereas fetal death had less consistent effects on the other hormones. All hormones had usually fallen considerably at the time of abortion, and in some individuals marked fluctuations in hormone levels were seen.
D000028:Abortion, Induced; D000650:Amnion; D004958:Estradiol / Q000097:blood*; D004964:Estriol / Q000097:blood*; D005260:Female; D005313:Fetal Death; D005318:Fetal Heart / Q000503:physiopathology; D006801:Humans; D007267:Injections; D007275:Injections, Intravenous; D010121:Oxytocin / Q000008:administration & dosage / Q000627:therapeutic use; D010928:Placental Lactogen / Q000097:blood*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011374:Progesterone / Q000097:blood*; D011458:Prostaglandins E / Q000008:administration & dosage / Q000627:therapeutic use*; D014508:Urea / Q000008:administration & dosage / Q000627:therapeutic use
D011458:Prostaglandins E; D011374:Progesterone; D004958:Estradiol; D010121:Oxytocin; D014508:Urea; D010928:Placental Lactogen; D004964:Estriol